Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06878742
PHASE1/PHASE2

Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants

Sponsor: Instituto de Investigación Hospital Universitario La Paz

View on ClinicalTrials.gov

Summary

Single centre, dose finding trial to establish the minimum effective dose of dobutamine required to treat hemodynamic insufficiency, defined as low superior vena cava (SVC) flow, in infants below 33 weeks' gestation during transitional circulation (first 72 hours from birth).

Official title: Dose-finding for Dobutamine During Transitional Circulation in the Very Preterm Infant

Key Details

Gender

All

Age Range

Any - 72 Hours

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-06-24

Completion Date

2029-06

Last Updated

2025-03-17

Healthy Volunteers

No

Interventions

DRUG

Intravenous dobutamine 5 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 5 mcg/kg/min.

DRUG

Intravenous dobutamine 7.5 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 7.5 mcg/kg/min.

DRUG

Intravenous dobutamine 10 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 10 mcg/kg/min.

DRUG

Intravenous dobutamine 12.5 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 12.5 mcg/kg/min.

DRUG

Intravenous dobutamine 15 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 15 mcg/kg/min.

Locations (3)

Hospital Universitario Quironsalud

Madrid, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

Hospital Universitario La Paz

Madrid, Spain